Corcept Therapeutics
CORT
#2078
Rank
โ‚น815.08 B
Marketcap
โ‚น7,735
Share price
1.71%
Change (1 day)
53.73%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น0.57 Billion

According to Corcept Therapeutics 's latest financial reports the company's total debt is โ‚น0.57 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น0.59 B4633.4%
2023-12-31โ‚น12.57 M-86.71%
2022-12-31โ‚น94.58 M141.59%
2021-12-31โ‚น39.15 M-79.01%
2020-12-31โ‚น0.18 B-24.41%
2019-12-31โ‚น0.24 B
2018-12-31N/A
2016-12-31โ‚น0.99 B0.2%
2015-12-31โ‚น0.99 B66.51%
2014-12-31โ‚น0.59 B68.34%
2013-12-31โ‚น0.35 B144.53%
2012-12-31โ‚น0.14 B
2010-12-31N/A-100%
2009-12-31โ‚น0.27 M-63.8%
2008-12-31โ‚น0.76 M-32.43%
2007-12-31โ‚น1.13 M-38.82%
2006-12-31โ‚น1.86 M-23.45%
2005-12-31โ‚น2.43 M
2003-12-31โ‚น23.84 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚น4.114 T 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.585 T 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น2.876 T 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น3.818 T 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.466 T 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น3.716 T 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น27.56 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚น10.77 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น54.28 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA